Friday, July 31, 2026

How the Ongoing Middle East Conflict is Impacting South Korea’s Medical Supply Chain

The Ministry of Health and Welfare discussed pharmaceutical supply stability amid Middle East conflict, ensuring proactive monitoring and response.

Churchill’s Iron Curtain Speech: The Moment that Defined the Cold War Divide

Churchill's "Iron Curtain" speech in 1946 symbolized the divide in Europe, urging unity against Soviet expansionism and promoting democracy.

Can Trump Transform North Korea Relations in 2026? Insights from Ex-White House Official

Alex Wong suggests Trump could foster better U.S.-North Korea talks by changing conditions, emphasizing dialogue and pressure for denuclearization.

Tag: precision medicine

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Radiopharmaceuticals Revolution: How Novartis’s 1.4 Billion USD Investment Transforms Cancer Treatment in South Korea

A 140 billion KRW investment by Novartis aims to enhance the radioactive pharmaceutical industry, focusing on precision medicine and Theranostics.

Unlocking Precision Medicine: New Antibody Design Targets KRAS(G12D) in Cancer Cells

Researchers at KAIST developed an antibody targeting KRAS(G12D) mutation, revolutionizing cancer treatment with precise immunotherapy.

Blood Test Alone May Predict Chemotherapy Response and Prognosis in Lymphoma Patients

South Korean researchers discover a mechanism reducing rituximab's effectiveness in DLBCL and propose a predictive blood biomarker.

Lunit Joins Global AI Consortium for Next-Gen Drug Development: What This Means for Precision Medicine

Lunit joins an AI consortium to enhance drug development through AI-driven pathology and biomarker analysis, collaborating with global firms.

NGeneBio Expands Blood Cancer Diagnostic Panel Supply to Seoul National University Bundang Hospital

NGeneBio expands its blood cancer diagnostic panel supply, achieving strong growth in South Korea and international markets.

How Korea’s Mega Projects Will Revolutionize the Biohealth Industry by 2026

South Korea's mega projects aim to revolutionize the biohealth industry through AI, semiconductors, and innovative healthcare solutions.

Korea University Anam Hospital Leads Precision Arrhythmia Care Through Customized Treatment [K-Medical Report]

Korea University Anam Hospital revolutionizes arrhythmia treatment with innovative techniques, enhancing patient care and precision medicine.

Samsung’s 176 Million USD Investment in Element Biosciences: What It Means for Precision Medicine in Asia

Samsung Electronics invests $176 million in Element Biosciences, enhancing its position in the precision medicine market with advanced genomic technology.

3billion Launches Genome-Based Newborn Screening Service Overseas to Expand Early Genetic Diagnosis

3billion launches 3B-NEO, a genomic newborn screening service to identify genetic disorders in infants, enhancing early diagnosis and treatment.

HLB to Spotlight Liver and Bile Duct Cancer Pipeline at ASCO 2026 With Standalone Global Booth

HLB will showcase liver cancer drug candidates at ASCO 2026, including promising combination therapies and precision medicine studies.

AACR 2026 Highlighted Shift Toward Patient-Centered Cancer Drug Development, Foundation Says

Cancer research is evolving towards patient-centered outcomes, integrating data and technology for better treatments, as noted at AACR 2026.

This New DNA Detection Breakthrough Could Change How Scientists Study Cancer Risk

KRISS and Wright State University developed a precise platform to detect ultra-trace damaged DNA, enhancing cancer research and treatment evaluation.

GC Cell Showcases Cold Chain Innovations the Spring Symposium of the Korean Society of Laboratory Medicine

GC Cell, GC Green Cross, and GC Genome showcased innovations in diagnostics at the 2023 Spring Symposium, enhancing precision medicine.

Penetrium Bioscience Announces Finalization of New Clinical Strategy for Targeted Cancer Therapies

Penetrium Bioscience reveals new clinical strategy to combat drug resistance in cancer therapies at AACR 2026, launching Phase 2 trials.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.